Making cell-free DNA testing accessible to all healthcare providers
Towards gene-based cardiac health

Towards gene-based cardiac health

Screening for familial hypercholesterolemia

(Results are received within 14 days)
Towards gene-based cardiac health
Gene Solutions divider

Prevalence and risk of disease

Top

1

gene-related cardiovascular diseases

1 in

200

individuals has the disease

About

90%

of patients are not detected early or receive effective treatment

3 to

4

times

Carrying a mutated gene increases the risk of cardiovascular disease

(*) Source: American College of Cardiology

What is the GenLDL test?

GenLDL is a test for diagnosing familial hypercholesterolemia—also known as hereditary hypercholesterolemia (FH). By analyzing mutations in three genes (LDLR, PCSK9, and APOB), the results are a strong indication of risk for the disease.

These test results have strong diagnostic value in supporting physicians and patients in selecting appropriate goals and treatment plans, establishing safe cholesterol thresholds (compared to those with normal hypercholesterolemia), and preventing dangerous complications, thereby improving survival rates (correct treatment prolongs the expected longevity).

EARLY PREVENTIVE SCREENING
FOR YOU AND YOUR FAMILY

Increasing the survival rate to 80 percent through early detection and timely treatment

LIFETIME VALUE GENETIC TESTING
OPTIMIZING THE COST OF SCREENING(*)

*Compared with annual biochemical testing

People with genetic mutations have a

Threefold increased risk

of atherosclerosis and coronary artery disease with the same blood LDL-C index.

- Scientific research published on the National Institute of Health website, USA -

Scope of the test

The test is recommended by

The American College of Cardiology

The American College of Cardiology

The European Society of Cardiology

The European Society of Cardiology

Who should perform GenLDL?

Individuals who have one of the three following criteria should perform the test:

1. High LDL cholesterol:
  • Untreated:

    • LDL-C >= 190mg/dL in adult
    • LDL-C >= 160mg/dL in children
  • Considered taking the test while on treatment but failed to reach treatment goals.
2. Family history of early coronary heart disease/early heart disease

(e.g., male < 55 years old, female < 60 years old)

3. If a family member has the disease, it is recommended that all members should be tested.

What do you get from the test package?

ecosystem.benefits.heading_1
Genetic counseling from geneticists

The team of experts and geneticists at Gene Solutions are always available to accompany you before and after each test and provide recommendations based on the results

ecosystem.benefits.heading_1
Guaranteed quality in every result

Next-generation sequencing technology (Illumina) from the United States was developed by Vietnam's leading medical advisors and a team of professionals. In only 14 days, a high-quality lab that complies with ISO standards will provide you with more than 99-percent-correct test results

ecosystem.benefits.heading_1
Simple to do and cost-effective

The USA standard DNA sampling kit, which allows you to collect samples at home in less than a minute, is painless and incredibly convenient

ecosystem.benefits.heading_1
Free testing for family members

If the initial test identifies a mutation, three family members will receive free testing. Take the initiative to prevent and protect your family's health

Testing process

Pre-test counselling
Pre-test counselling
Blood collection and extracellular DNA separation
Blood collection and extracellular DNA separation
Sequencing of cell-free DNA
Sequencing of cell-free DNA
Returning results and post-test counselling
Returning results and post-test counselling
CTA Form - Gene Solutions

Genetic consultation with our doctors

Besides you and your family before and after the test.